Coronavirus Update: J&J’s Single Shot Could Catch Up With Frontrunners

Phase III Trials Launched

Company is confident that data readout from pivotal trial could be ready before the end of 2020.  

Janssen_Johnson_Johnson
The COVID-19 vaccine project is being led by the Janssen research center in Leiden, the Netherlands.

More from COVID-19

More from Scrip